Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS)

Summary

Patients with an acute exacerbation of Relapsing-Remitting Multiple Sclerosis or with Clinically Isolated Syndrome receive either one single infusion of Nanocort or three daily infusions of SoluMedrol. Main objective is to assess the occurrence of new gadolinium-enhanced T1-weighted lesions at week 8 vs week 1 after treatment.

Timeline

Start

2009-12

Primary completion

2011-11

Completion

2011-11

Drugs

Indications